Rate this post

F. Hofmann (Germany): Molecular pharmacology of calcium channels.

A. Zanchetti (Italy): The view of a clinician on the bénéfice of calcium channel blockers in hypertension.

T. Godfraind (Belgium): CCBs control of gene reprogramming and gene upregulation in salt-dependent hypertension.

U. Ruegg (Switzerland): Pharmacology of cellular calcium regulation in neuromuscular diseases.

E. Ertel (Switzerland): Pharmacology of T-type calcium channels.